Skip to main content
OpenTrials

Clinical trial condition

Primary Sclerosing Cholangitis

Explore clinical trials studying Primary Sclerosing Cholangitis. Study availability and eligibility vary by location and protocol.

69 public trials 21 recruiting studies

Primary Sclerosing Cholangitis trial results

NCT03872921

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholangitis, +3 more
Locations
  • Medical University of Vienna, Department of Internal Medicine III Vienna, Austria
  • Medical School Hannover Hanover, Lower Saxonia, Germany
Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholangitis, +3 more
Locations
  • Scripps Clinic Torrey Pines - site P83 La Jolla, California, United States
  • UC Davis Health System - Midtown Ambulatory Care Center - site P79 Sacramento, California, United States
  • Northwestern University - site P77 Chicago, Illinois, United States
  • Massachusetts General Hospital - site P95 Boston, Massachusetts, United States
View all 33 locations
Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholangitis, +3 more
Locations
  • California Liver Research Institute Pasadena, California, United States
  • Stanford University School of Medicine Redwood City, California, United States
  • University of California, Davis Medical Center Sacramento, California, United States
  • California Pacific Medical Center Research Institute San Francisco, California, United States
View all 60 locations
Conditions
Autoimmune Diseases, Autoimmune Hepatitis, Bile Duct Diseases, +33 more
Locations
  • Leiden University Medical Centre Leiden, Netherlands
  • Addenbrookes Hospital Cambridge, Cambridgeshire, United Kingdom
  • University of Oxford Centre for Clinical Magnetic Resonance Research (OCMR) Oxford, Oxfordshire, United Kingdom
  • Southampton General Hospital Southampton, United Kingdom
Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholangitis, +3 more
Locations
  • NGM Clinical Study Site 118 Sacramento, California, United States
  • NGM Clinical Study Site 112 San Clemente, California, United States
  • NGM Clinical Study Site 127 San Francisco, California, United States
  • NGM Clinical Study Site 106 Aurora, Colorado, United States
View all 38 locations